AMJ Financial Wealth Management Has $3.41 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

AMJ Financial Wealth Management cut its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 55.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,350 shares of the company's stock after selling 14,213 shares during the quarter. AMJ Financial Wealth Management's holdings in HCA Healthcare were worth $3,407,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Legacy Investment Solutions LLC acquired a new stake in HCA Healthcare during the 3rd quarter worth about $39,000. Capital Performance Advisors LLP purchased a new position in HCA Healthcare during the third quarter valued at approximately $41,000. Whipplewood Advisors LLC purchased a new stake in HCA Healthcare in the 4th quarter worth approximately $31,000. Activest Wealth Management grew its holdings in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after acquiring an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. boosted its position in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after purchasing an additional 50 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm's stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock traded up $0.78 during trading on Thursday, hitting $320.41. 220,710 shares of the company's stock traded hands, compared to its average volume of 1,676,073. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The company has a market cap of $79.57 billion, a PE ratio of 14.59, a PEG ratio of 1.10 and a beta of 1.64. The firm's fifty day moving average price is $315.76 and its 200 day moving average price is $348.17. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the company posted $5.90 earnings per share. Analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.90%. The ex-dividend date is Monday, March 17th. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's dividend payout ratio (DPR) is presently 13.11%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Royal Bank of Canada reduced their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research note on Monday, January 27th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. KeyCorp reduced their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a research note on Tuesday, January 7th. Morgan Stanley cut their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a research report on Tuesday, December 17th. Finally, Truist Financial cut their price objective on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.